Current management of severe acquired aplastic anemia

Overall survival in severe aplastic anemia has markedly improved in the past four decades due to advances in stem cell transplantation, immunosuppressive therapies and supportive care. Horse anti-thymocyte globulin plus cyclosporine is the standard immunosuppressive regimen in severe aplastic anemia...

Full description

Bibliographic Details
Main Author: Phillip Scheinberg
Format: Article
Language:English
Published: Instituto Israelita de Ensino e Pesquisa Albert Einstein 2011-06-01
Series:Einstein (São Paulo)
Subjects:
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1679-45082011000200229&tlng=en